Maze Therapeutics (MAZE) Cash from Operations (2024 - 2026)
Maze Therapeutics' Cash from Operations history spans 3 years, with the latest figure at 39113000.0 for Q1 2026.
- On a quarterly basis, Cash from Operations fell 32.51% to 39113000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was 121537000.0, a 273.93% decrease, with the full-year FY2025 number at 111940000.0, down 247.38% from a year prior.
- Cash from Operations hit 39113000.0 in Q1 2026 for Maze Therapeutics, down from 27730000.0 in the prior quarter.
- Over the last five years, Cash from Operations for MAZE hit a ceiling of 145048000.0 in Q2 2024 and a floor of 39113000.0 in Q1 2026.
- Historically, Cash from Operations has averaged 8344333.33 across 3 years, with a median of 24642000.0 in 2025.
- The widest YoY moves for Cash from Operations: up 6.19% in 2025, down 120.72% in 2025.
- Tracing MAZE's Cash from Operations over 3 years: stood at 22452000.0 in 2024, then fell by 23.51% to 27730000.0 in 2025, then plummeted by 41.05% to 39113000.0 in 2026.
- Business Quant data shows Cash from Operations for MAZE at 39113000.0 in Q1 2026, 27730000.0 in Q4 2025, and 24642000.0 in Q3 2025.